114 related articles for article (PubMed ID: 24851620)
1. Diagnostic value of MPO in patients admitted for suspected acute coronary syndrome--a study of adult in Mostar, Bosnia and Herzegovina.
Vasilj M; Starcević B; Volarić M; Jelavić B; Leventić M; Cuk D; Corić S
Coll Antropol; 2014 Mar; 38(1):213-7. PubMed ID: 24851620
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes.
Sawicki M; Sypniewska G; Kozinski M; Gruszka M; Krintus M; Obonska K; Pilaczynska-Cemel M; Kubica J
Eur J Clin Invest; 2011 Jun; 41(6):667-71. PubMed ID: 21226709
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic performance of myeloperoxidase plasma levels compared with sensitive troponins in patients admitted with acute onset chest pain.
Rudolph V; Keller T; Schulz A; Ojeda F; Rudolph TK; Tzikas S; Bickel C; Meinertz T; Münzel T; Blankenberg S; Baldus S
Circ Cardiovasc Genet; 2012 Oct; 5(5):561-8. PubMed ID: 22923422
[TBL] [Abstract][Full Text] [Related]
4. Is it safe to discharge patients from accident and emergency using a rapid point of care Triple Cardiac Marker test to rule out acute coronary syndrome in low to intermediate risk patients presenting with chest pain?
Rathore S; Knowles P; Mann AP; Dodds PA
Eur J Intern Med; 2008 Nov; 19(7):537-40. PubMed ID: 19013384
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase is not useful for the early assessment of patients with chest pain.
Eggers KM; Dellborg M; Johnston N; Oldgren J; Swahn E; Venge P; Lindahl B
Clin Biochem; 2010 Feb; 43(3):240-5. PubMed ID: 19822136
[TBL] [Abstract][Full Text] [Related]
6. Predictors of myocardial damage prior to hospital admission among patients with acute chest pain or other symptoms raising a suspicion of acute coronary syndrome.
Svensson L; Isaksson L; Axelsson C; Nordlander R; Herlitz J
Coron Artery Dis; 2003 May; 14(3):225-31. PubMed ID: 12702926
[TBL] [Abstract][Full Text] [Related]
7. High-sensitivity troponin T as a diagnostic tool for acute coronary syndrome in the real world: an observational study.
Borna C; Thelin J; Ohlin B; Erlinge D; Ekelund U
Eur J Emerg Med; 2014 Jun; 21(3):181-8. PubMed ID: 23751287
[TBL] [Abstract][Full Text] [Related]
8. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.
Viswanathan K; Kilcullen N; Morrell C; Thistlethwaite SJ; Sivananthan MU; Hassan TB; Barth JH; Hall AS
J Am Coll Cardiol; 2010 Jun; 55(23):2590-8. PubMed ID: 20513600
[TBL] [Abstract][Full Text] [Related]
9. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
[TBL] [Abstract][Full Text] [Related]
10. Rapid risk stratification in suspected acute coronary syndrome using serial multiple cardiac biomarkers: a pilot study.
Macdonald SP; Nagree Y
Emerg Med Australas; 2008 Oct; 20(5):403-9. PubMed ID: 18973637
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
[TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase in the diagnosis of acute coronary syndromes: the importance of spectrum.
Peacock WF; Nagurney J; Birkhahn R; Singer A; Shapiro N; Hollander J; Glynn T; Nowak R; Safdar B; Miller C; Peberdy M; Counselman F; Chandra A; Kosowsky J; Neuenschwander J; Schrock J; Plantholt S; Lewandrowski E; Wong V; Kupfer K; Diercks D
Am Heart J; 2011 Nov; 162(5):893-9. PubMed ID: 22093206
[TBL] [Abstract][Full Text] [Related]
13. Prognostic information of glycogen phosphorylase isoenzyme BB in patients with suspected acute coronary syndrome.
Lillpopp L; Tzikas S; Ojeda F; Zeller T; Baldus S; Bickel C; Sinning CR; Wild PS; Genth-Zotz S; Warnholtz A; Lackner KJ; Münzel T; Blankenberg S; Keller T
Am J Cardiol; 2012 Nov; 110(9):1225-30. PubMed ID: 22818785
[TBL] [Abstract][Full Text] [Related]
14. Heart-type fatty acid binding protein and the diagnosis of acute coronary syndrome in the ED.
Freund Y; Chenevier-Gobeaux C; Leumani F; Claessens YE; Allo JC; Doumenc B; Cosson C; Bonnet P; Riou B; Ray P
Am J Emerg Med; 2012 Oct; 30(8):1378-84. PubMed ID: 22169585
[TBL] [Abstract][Full Text] [Related]
15. Abnormal troponin I levels during pregnancy without acute coronary syndrome and without hypertensive disorders.
Patanè S; Marte F; Di Bella G; Davi' M
Int J Cardiol; 2008 Aug; 128(2):e47-9. PubMed ID: 17544531
[No Abstract] [Full Text] [Related]
16. Combination of copeptin and troponin assays to rapidly rule out non-ST elevation myocardial infarction in the emergency department.
Charpentier S; Maupas-Schwalm F; Cournot M; Elbaz M; Botella JM; Lauque D
Acad Emerg Med; 2012 May; 19(5):517-24. PubMed ID: 22594355
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.
Bonaca M; Scirica B; Sabatine M; Dalby A; Spinar J; Murphy SA; Jarolim P; Braunwald E; Morrow DA
J Am Coll Cardiol; 2010 May; 55(19):2118-24. PubMed ID: 20447535
[TBL] [Abstract][Full Text] [Related]
18. [Predictors of acute coronary syndrome without ST segment elevation and risk stratification in the chest pain unit].
Gabrielli LA; Castro PF; Verdejo HE; McNab PA; Llevaneras SA; Mardonez JM; Corbalán RL
Rev Med Chil; 2008 Apr; 136(4):442-50. PubMed ID: 18769786
[TBL] [Abstract][Full Text] [Related]
19. Performance of glycogen phosphorylase isoenzyme BB is weak in the detection of patients with non-ST-elevation acute coronary syndrome.
Meune C; Wahbi K; Weber S; Zuily S; Cynober L; Chenevier-Gobeaux C
Clin Biochem; 2011 Nov; 44(16):1343-5. PubMed ID: 21820423
[TBL] [Abstract][Full Text] [Related]
20. Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay.
Apple FS; Smith SW; Pearce LA; Murakami MM
Clin Biochem; 2012 Jul; 45(10-11):711-3. PubMed ID: 22465126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
